In the largest genomic study ever targeting single-organ cancers, Japanese researchers have completed a whole-genome analysis of 300 liver cancer patients, discovering that liver cancer among Japanese can be broken down into six types.
The study, jointly carried out by a number of institutions including the National Cancer Center, the Riken research institute and the University of Tokyo, hopes to contribute to the development of new diagnostic methods and personalized drug therapies.
Unable to view this article?
This could be due to a conflict with your ad-blocking or security software.
Please add japantimes.co.jp and piano.io to your list of allowed sites.
If this does not resolve the issue or you are unable to add the domains to your allowlist, please see out this support page.
We humbly apologize for the inconvenience.